Clinical Trial

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

Study acronym: DiaTRUST
Recruiting
View on ClinicalTrials.gov →
Summary
The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control), and a usual care group (control). Both the intelligent telemonitoring group and the telemonitoring group will use various devices at home. Hospital staff will monitor their data for three months. In the intelligent telemonitoring group, hospital staff and participants will be supported by decision-support algorithms in the management of insulin treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-12-14; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2026-02-05
Trial Details
NCT Number NCT06185296
Lead Sponsor Aalborg University Hospital
Collaborators: Novo Nordisk A/S, DexCom, Inc.
Conditions Type 2 Diabetes Treated With Insulin
Enrollment 51 participants
Start Date 2025-11-15
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-09